Clinical Trial

A Clinical Trial to Evaluate the Bioequivalence of AD-116A and AD-1161 Under Fed Conditions in Healthy Adult Male Volunteers

Name: A Clinical Trial to Evaluate the Bioequivalence of AD-116A and AD-1161 Under Fed Conditions in Healthy Adult Male Volunteers — clinical trial record (NCT07722871)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting Phase 1

View on ClinicalTrials.gov →

Summary

This study compares and evaluates the bioequivalence of AD-116A and AD-1161 in healthy adult male volunteers under fed conditions.

Protocol Amendment History 1 amendment

This ClinicalTrials.gov record has been amended once since 2026-07-20.

Trial Details

NCT Number	NCT07722871
Lead Sponsor	Addpharma Inc.
Conditions	Benign Prostatic Hyperplasia
Enrollment	44 participants
Start Date	2026-07
Primary Completion	2026-10 (estimated)
Study Completion	2026-10 (estimated)
Updated on ClinicalTrials.gov	2026-07-27